A micropatterning platform for quantifying interaction kinetics between the T cell receptor and an intracellular binding protein.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
01 03 2019
Historique:
received: 25 09 2018
accepted: 01 02 2019
entrez: 3 3 2019
pubmed: 3 3 2019
medline: 18 9 2020
Statut: epublish

Résumé

A complete understanding of signaling processes at the plasma membrane depends on a quantitative characterization of the interactions of the involved proteins. Fluorescence recovery after photobleaching (FRAP) is a widely used and convenient technique to obtain kinetic parameters on protein interactions in living cells. FRAP experiments to determine unbinding time constants for proteins at the plasma membrane, however, are often hampered by non-specific contributions to the fluorescence recovery signal. On the example of the interaction between the T cell receptor (TCR) and the Syk kinase ZAP70, we present here an approach based on protein micropatterning that allows the elimination of such non-specific contributions and considerably simplifies analysis of FRAP data. Specifically, detection and reference areas are created within single cells, each being either enriched or depleted in TCR, which permits the isolation of ZAP70-TCR binding in a straight-forward manner. We demonstrate the applicability of our method by comparing it to a conventional FRAP approach.

Identifiants

pubmed: 30824760
doi: 10.1038/s41598-019-39865-0
pii: 10.1038/s41598-019-39865-0
pmc: PMC6397226
doi:

Substances chimiques

Receptors, Antigen, T-Cell 0
ZAP-70 Protein-Tyrosine Kinase EC 2.7.10.2
ZAP70 protein, human EC 2.7.10.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3288

Subventions

Organisme : Austrian Science Fund FWF
ID : V 538
Pays : Austria

Références

J Cell Biol. 2004 Jun 7;165(5):735-46
pubmed: 15173190
Nat Commun. 2015 Apr 21;6:6969
pubmed: 25897971
Biophys J. 2010 Nov 3;99(9):2737-47
pubmed: 21044570
Biophys J. 1976 Sep;16(9):1055-69
pubmed: 786399
J Cell Biol. 2002 Sep 30;158(7):1263-75
pubmed: 12356870
Biochemistry. 2008 Oct 28;47(43):11239-50
pubmed: 18831540
Biomolecules. 2018 May 17;8(2):
pubmed: 29772810
J Biol Chem. 2004 Apr 9;279(15):15274-80
pubmed: 14729907
PLoS One. 2014 Mar 21;9(3):e92151
pubmed: 24658383
J Biol Chem. 2007 May 11;282(19):14576-85
pubmed: 17376773
Nat Methods. 2008 Dec;5(12):1053-60
pubmed: 18997782
J Cell Biol. 2014 Nov 10;207(3):407-18
pubmed: 25385185
J Exp Med. 2005 Oct 17;202(8):1031-6
pubmed: 16216891
Sci Rep. 2014 Nov 19;4:7111
pubmed: 25407951
Biophys J. 2004 Jun;86(6):3473-95
pubmed: 15189848
Nat Immunol. 2015 Sep;16(9):961-9
pubmed: 26237552
J Immunol. 1980 Jun;124(6):2708-13
pubmed: 6966296
Nat Commun. 2016 Feb 04;7:10489
pubmed: 26843440
Mol Cell. 2016 Apr 7;62(1):7-20
pubmed: 27052731
Eur Biophys J. 2009 Jun;38(5):649-61
pubmed: 19238375
Nat Immunol. 2017 Jan;18(1):86-95
pubmed: 27869819
Methods Mol Biol. 2017;1550:261-270
pubmed: 28188535
J Biol Chem. 1996 Jan 12;271(2):695-701
pubmed: 8557675
Nat Cell Biol. 2003 Sep;Suppl:S7-14
pubmed: 14562845
Small. 2017 Apr;13(15):
pubmed: 28151581
Traffic. 2005 Oct;6(10):918-29
pubmed: 16138905
Proc Natl Acad Sci U S A. 2008 Jun 3;105(22):7791-6
pubmed: 18505845
Proc Natl Acad Sci U S A. 1984 Mar;81(5):1509-13
pubmed: 6231642
Trends Cell Biol. 2005 Feb;15(2):84-91
pubmed: 15695095
Immunol Rev. 2009 Mar;228(1):41-57
pubmed: 19290920
Opt Express. 2009 Mar 16;17(6):4685-704
pubmed: 19293898
Nat Immunol. 2018 Mar;19(3):203-205
pubmed: 29476188

Auteurs

Viktoria Motsch (V)

Institute of Applied Physics, TU Wien, Wiedner Hauptstrasse 8-10, 1040, Vienna, Austria.

Mario Brameshuber (M)

Institute of Applied Physics, TU Wien, Wiedner Hauptstrasse 8-10, 1040, Vienna, Austria.

Florian Baumgart (F)

Institute of Applied Physics, TU Wien, Wiedner Hauptstrasse 8-10, 1040, Vienna, Austria.

Gerhard J Schütz (GJ)

Institute of Applied Physics, TU Wien, Wiedner Hauptstrasse 8-10, 1040, Vienna, Austria.

Eva Sevcsik (E)

Institute of Applied Physics, TU Wien, Wiedner Hauptstrasse 8-10, 1040, Vienna, Austria. eva.sevcsik@tuwien.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH